Craig Bottomley
No más puestos en curso
Perfil
Craig Bottomley is the founder of Halcygen Pharmaceuticals Ltd., which was founded in 2005.
He held the title of Chief Operating Officer & Executive Director from 2005 to 2010.
Mr. Bottomley's former jobs include Managing Director at GUD Holdings Ltd., Director at Mirrabooka Investments Ltd., Managing Director at Pacific Dunlop Cables Group, and Non-Executive Director at BWX Ltd.
from 2013 to 2017.
He also held the position of Non-Executive Director at Star Combo Pharma Ltd.
in 2019.
Antiguos cargos conocidos de Craig Bottomley.
Empresas | Cargo | Fin |
---|---|---|
STAR COMBO PHARMA LIMITED | Director/Miembro de la Junta | 16/08/2019 |
BWX | Director/Miembro de la Junta | 02/03/2017 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Fundador | 22/11/2010 |
MAYNE PHARMA GROUP LIMITED | Director de Operaciones | 29/07/2010 |
GUD HOLDINGS LIMITED | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
MAYNE PHARMA GROUP LIMITED | Health Technology |
BWX | Consumer Non-Durables |
GUD HOLDINGS LIMITED | Consumer Durables |
STAR COMBO PHARMA LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | Health Technology |
Mirrabooka Investments Ltd.
Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
Pacific Dunlop Cables Group |
- Bolsa de valores
- Insiders
- Craig Bottomley